Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 4/20 | 0.43 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.35 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.35 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | APEX1 | P27695 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | HTR1A | P08908 | 1/20 | 0.32 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.32 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL810800 | 0.89 | THRB (0.47) | THRBTSHRCHRM2CHRM4CHRM5 | |
| Urea SCHEMBL7101033 | 0.80 | THRB (0.48) | THRBTSHRALDH1A1TDP1POLB | |
| SCHEMBL245045 | 0.79 | THRB (0.61) | THRBTSHRCHRM2CHRM4CHRM5 | |
| SCHEMBL21292110 | 0.79 | THRB (0.61) | THRBTSHRCHRM2CHRM4CHRM5 | |
| SCHEMBL3647636 | 0.78 | TSHR (0.44) | THRBTSHRALDH1A1TDP1POLB | |
| SCHEMBL809330 | 0.77 | THRB (0.53) | THRBTSHRALDH1A1TDP1POLB | |
| SCHEMBL27591414 | 0.77 | TSHR (0.56) | THRBTSHRALDH1A1TDP1POLB | |
| SCHEMBL3098708 | 0.76 | TSHR (0.47) | THRBTSHRALDH1A1TDP1POLB | |
| SCHEMBL5610739 | 0.76 | TSHR (0.60) | THRBTSHRCHRM2CHRM4CHRM5 | |
| Urea SCHEMBL15263286 | 0.75 | THRB (0.65) | THRBTSHRCHRM2CHRM4CHRM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9345811-B2 | Medical antimicrobial composition and medical device comprising the same | TORAY INDUSTRIES, INC. (JP) | 2016-05-24 | — | — | US | disclosed |
| EP-2275154-B1 | ANTIBACTERIAL COMPOSITION FOR MEDICAL USE AND MEDICAL DEVICE | TORAY INDUSTRIES (JP) | 2015-07-01 | — | — | EP | disclosed |
| US-20140120146-A1 | MEDICAL ANTIMICROBIAL COMPOSITION AND MEDICAL DEVICE COMPRISING THE SAME | TORAY INDUSTRIES, INC. (JP) | 2014-05-01 | — | — | US | disclosed |
| US-8652499-B2 | Medical antimicrobial composition and medical device comprising the same | TORAY INDUSTRIES, INC. (JP) | 2014-02-18 | — | — | US | disclosed |
| EP-2275154-A1 | ANTIBACTERIAL COMPOSITION FOR MEDICAL USE AND MEDICAL DEVICE | Toray Industries, Inc. (JP) | 2011-01-19 | — | — | EP | disclosed |
| US-20110008403-A1 | MEDICAL ANTIMICROBIAL COMPOSITION AND MEDICAL DEVICE COMPRISING THE SAME | TORAY INDUSTRIES, INC. (JP) | 2011-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110008403-A1 | MEDICAL ANTIMICROBIAL COMPOSITION AND MEDICAL DEVICE COMPRISING THE SAME | AAAS, MMS19, MSN | THRB 4581/4885TSHR 4642/4885CHRM2 4694/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.